11 companies

Beijing Tong Ren Tang Chinese Medicine

Market Cap: HK$7.9b

Engages in the manufacture, retail, and wholesale of healthcare products and Chinese medicine to wholesalers and individuals.

3613

HK$9.43

7D

7.5%

1Y

17.9%

Tong Ren Tang Technologies

Market Cap: HK$6.3b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

1666

HK$4.93

7D

5.6%

1Y

-3.3%

Consun Pharmaceutical Group

Market Cap: HK$12.7b

Researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People’s Republic of China.

1681

HK$15.00

7D

-0.07%

1Y

76.3%

Essex Bio-Technology

Market Cap: HK$2.6b

An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.

1061

HK$4.61

7D

5.5%

1Y

75.3%

Shandong Xinhua Pharmaceutical

Market Cap: HK$10.6b

Develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally.

719

HK$7.22

7D

3.4%

1Y

22.0%

CSPC Pharmaceutical Group

Market Cap: HK$87.6b

An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.

1093

HK$7.95

7D

5.3%

1Y

53.2%

Shanghai Haohai Biological Technology

Market Cap: HK$11.8b

Shanghai Haohai Biological Technology Co., Ltd.

6826

HK$28.12

7D

1.4%

1Y

-4.4%

China Shineway Pharmaceutical Group

Market Cap: HK$6.9b

An investment holding company, engages in the research and development, manufacture, and trade of Chinese pharmaceutical products in the People’s Republic of China and Hong Kong.

2877

HK$9.17

7D

3.3%

1Y

10.1%

Pak Fah Yeow International

Market Cap: HK$751.1m

An investment holding company, engages in manufacturing, marketing, and distributing healthcare products under the Hoe Hin brand name.

239

HK$2.41

7D

-1.6%

1Y

0.8%

Dawnrays Pharmaceutical (Holdings)

Market Cap: HK$1.8b

An investment holding company, develops, manufactures, and sells non-patented pharmaceutical medicines in Mainland China and internationally.

2348

HK$1.17

7D

-0.8%

1Y

-6.4%

Jacobson Pharma

Market Cap: HK$2.9b

Through its subsidiaries, engages in the research, development, production, sale, and distribution of medicine and drugs in Hong Kong, Mainland China, Macau, Singapore, and internationally.

2633

HK$1.46

7D

1.4%

1Y

94.7%